Total Voting Rights
10 May, 2013
Sareum Notified of Grant Award
24 April, 2013
Sareum and SRI International Announce Co-development Agreement
22 April, 2013
Issue of Equity
25 March, 2013
Adviser Change of Name
19 March, 2013
News feed
requires RSS news reader
| Sareum Holdings | |
| Last Trading | 0.88 |
| Trade Time | 16:33am |
| Change | -0.07 |
| Open | 0.92 |
| Day's Range | 0.84 - 1.00 |
| Volume | 14547633 |
Sareum's small molecule drug discovery expertise is building value by developing drug candidates, focused on cancer and auto-immune disease, for licencing to pharmaceutical and biotechnology companies
Learn more about Sareum’s pipeline of targeted small molecule drug candidates
Sareum's December 2012 Half-Yearly Report and 2012 Annual Report and Accounts can be downloaded from our Information Page
Website last updated on: 21-May-2012
Requires MS Word
Requires Adobe Acrobat Reader